Compare McKesson Corporation (MCK) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs ProShares UltraPro Short QQQ ETF — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while ProShares UltraPro Short QQQ ETF trades at $32.95 (market cap $2.23B). The key difference: McKesson Corporation is far larger — about 48.6× ProShares UltraPro Short QQQ ETF's market cap, and McKesson Corporation pays a 0.4% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| MCK | SQQQ | |
|---|---|---|
Market Cap | $108.46B | $2.23B |
Volume | 712,607 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $995.69 | $89.43 |
52-Week Low | $725.17 | $31.83 |
Typical Hold Time | 74 Days | 12 Days |
Enterprise Value | $115.00B | — |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
SQQQ (ProShares UltraPro Short QQQ) is trading at $33.37, up 4.02% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure while oscillators remain neutral. Recent news highlights SQQQ's role as a hedging tool against Nasdaq 100 declines, with financial media noting its strategic use during tech sector volatility.
The outlook remains tied to Nasdaq 100 performance, with SQQQ positioned to benefit from further tech weakness. Key risks include timing sensitivity and decay from daily rebalancing. Investment opportunity exists for tactical hedging but requires careful risk management due to the leveraged inverse structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
